Audited Supplier
1.0g
Injection
IV
Adult
Powder
Powder
Biological Products
Chemical Synthesis
C22h22n6o7s2·5H2O
636.65
White or Almost White Crystalline Powder
Without
Cartoon
1.0g/10ml vial
China
3004909099
Product Description
Ceftazidime for injection
Ingredients
The main ingredient of this product is ceftazidime, with appropriate amount of sodium carbonate as cosolvent
This product can be used for septicemia caused by sensitive gram-negative bacilli, infection of lower respiratory system, infection of celiac biliary system, complicated urinary tract infection and severe skin and soft tissue infection.
It is especially suitable for the infection of immunodeficient patients, hospital infection and central nervous system infection caused by Gram negative bacilli or Pseudomonas aeruginosa.
Usage and dosage
Before use, add a proper amount of sterile water for injection to make it dissolve.
Septicemia, lower respiratory system infection and biliary system infection were 4-6 g / day, divided into 2-3 times of intravenous drip or injection, and the course of treatment was 10-14 days.
Urinary tract infection and severe skin and soft tissue infection, 2-4G / day, two times of intravenous drip or injection, 7-14 days.
For some life-threatening infections, severe Pseudomonas aeruginosa infection and central nervous system infection, 150-200mg / kg per day may be taken in increments as appropriate, and intravenous drip or injection may be made three times.
The daily dosage of infants is 30-100mg / kg, divided into 2-3 intravenous drip, the maximum daily dose is not more than 6G.
Usage and dosage
Before use, add a proper amount of sterile water for injection to make it dissolve.
Septicemia, lower respiratory system infection and biliary system infection were 4-6 g / day, divided into 2-3 times of intravenous drip or injection, and the course of treatment was 10-14 days.
Urinary tract infection and severe skin and soft tissue infection, 2-4G / day, two times of intravenous drip or injection, 7-14 days.
For some life-threatening infections, severe Pseudomonas aeruginosa infection and central nervous system infection, 150-200mg / kg per day may be taken in increments as appropriate, and intravenous drip or injection may be made three times.
The daily dosage of infants is 30-100mg / kg, divided into 2-3 intravenous drip, the maximum daily dose is not more than 6G.
Usage and dosage
Before use, add a proper amount of sterile water for injection to make it dissolve.
Septicemia, lower respiratory system infection and biliary system infection were 4-6 g / day, divided into 2-3 times of intravenous drip or injection, and the course of treatment was 10-14 days.
Urinary tract infection and severe skin and soft tissue infection, 2-4G / day, two times of intravenous drip or injection, 7-14 days.
For some life-threatening infections, severe Pseudomonas aeruginosa infection and central nervous system infection, 150-200mg / kg per day may be taken in increments as appropriate, and intravenous drip or injection may be made three times.
The daily dosage of infants is 30-100mg / kg, divided into 2-3 intravenous drip, the maximum daily dose is not more than 6G
Adverse reaction
The adverse reactions of this product are rare and mild, the incidence is about 2.5%. A few patients developed skin rash (0.5% - 2%), pruritus and drug fever; nausea, diarrhea and abdominal pain; mild phlebitis at the injection site; occasionally, transient serum transaminase (SGPT), blood urea nitrogen and blood creatinine increased slightly; leucocyte, thrombocytopenia and eosinophilia increased. Mild or moderate reversible reduction in glomerular filtration rate during the course of treatment has also been reported. Coombs test was positive in 5% of patients, hemolytic anemia and thrombocytosis were rare, reversible neutropenia was seen in individual patients. The incidence of double infection was 2.5%. The common pathogens were Enterococcus and Candida.
Contraindication
It is forbidden to use in those who have a history of allergic reaction to this product or cephalosporin antibiotics. Patients with a history of penicillin anaphylactic shock should avoid using this product.
